p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action:...

8

Transcript of p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action:...

Page 1: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 2: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 3: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 4: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 5: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 6: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 7: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes
Page 8: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

060812 EEOC Response (DANISH)

060812 EEOC Response (DANISH)

CALGB/CTSU 40101 Cyclophosphamide and doxorubicin (CA …ncctg.mayo.edu/thebook/Books/Fall_2009/40101_Full_Report.pdfJune 2009 Breast Committee CALGB 40101 Breast - 4 Adverse Events

CALGB/CTSU 40101 Cyclophosphamide and doxorubicin (CA …ncctg.mayo.edu/thebook/Books/Fall_2009/40101_Full_Report.pdfJune 2009 Breast Committee CALGB 40101 Breast - 4 Adverse Events

060812 EEOC Response (ALBANIAN)

060812 EEOC Response (ALBANIAN)

060812 EEOC Response (BULGARIAN)

060812 EEOC Response (BULGARIAN)

060812 EEOC Response (BENGALI)

060812 EEOC Response (BENGALI)

060812 EEOC Response (HINDI)

060812 EEOC Response (HINDI)

CALGB 40903: Phase II Single-Arm Study of Neoadjuvant ......Clinical Research Professionals Education Meeting Friday May 9, 2014 CALGB 40903: Phase II Single-Arm Study of Neoadjuvant

CALGB 40903: Phase II Single-Arm Study of Neoadjuvant ......Clinical Research Professionals Education Meeting Friday May 9, 2014 CALGB 40903: Phase II Single-Arm Study of Neoadjuvant

060812 EEOC Response (CHINESE - Simplified)

060812 EEOC Response (CHINESE - Simplified)

CALGB/CTSU 40101 Cyclophosphamide and doxorubicin (CA x 4 ...ncctg.mayo.edu/thebook/Books/Fall_2009/40101_report.pdf · June 2009 Breast Committee CALGB 40101 Breast - 4 Adverse Events

CALGB/CTSU 40101 Cyclophosphamide and doxorubicin (CA x 4 ...ncctg.mayo.edu/thebook/Books/Fall_2009/40101_report.pdf · June 2009 Breast Committee CALGB 40101 Breast - 4 Adverse Events

060812 EEOC Response (KANNADA)

060812 EEOC Response (KANNADA)

060812 EEOC Response (JAPANESE)

060812 EEOC Response (JAPANESE)

060812 EEOC Response (ARABIC)

060812 EEOC Response (ARABIC)

E1496: ECOG and CALGB

E1496: ECOG and CALGB

060812 EEOC Response (PORTUGUESE)

060812 EEOC Response (PORTUGUESE)

Integrated commodity daily research report 060812

Integrated commodity daily research report 060812

060812 EEOC Response (MALAY)

060812 EEOC Response (MALAY)

060812 EEOC Response (ROMANIAN)

060812 EEOC Response (ROMANIAN)

060812 EEOC Response (SPANISH)

060812 EEOC Response (SPANISH)

060812 EEOC Response (BELARUSIAN)

060812 EEOC Response (BELARUSIAN)

060812 EEOC Response (TAMIL)

060812 EEOC Response (TAMIL)